{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:53:03Z","timestamp":1788821583783,"version":"build-2803163510"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with hematological diseases often experience cerebrovascular complications including ischemic stroke, intracerebral and subarachnoid hemorrhage, microbleeds, posterior reversible encephalopathy syndrome, and dural sinus and cerebral vein thrombosis (CVT). In this update, we will review recent advances in the management of cerebrovascular diseases in the context of myeloproliferative neoplasms, leukemias, lymphomas, multiple myeloma, POEMS, paroxysmal nocturnal hemoglobinuria (PNH), thrombotic thrombocytopenic purpura (TTP), and sickle-cell disease. In acute ischemic stroke associated with hematological diseases, thrombectomy can in general be applied if there is a large vessel occlusion. Intravenous thrombolysis can be used in myeloproliferative neoplasms and sickle-cell anemia, but in other diseases, a case-by-case evaluation of the bleeding risks is mandatory. Patients with sickle-cell disease and acute stroke need very often to be transfused. In PNH, acute ischemic stroke patients must be anticoagulated. Most patients with CVT can be treated with low-molecular weight heparin (LMWH) acutely, even those with leukemias. Prevention of recurrence of cerebral thrombotic events depends on the control of the underlying disease, combined in some conditions with antithrombotic drugs. The recent introduction of specific monoclonal antibodies in the treatment of PHN and TTP has dramatically reduced the risk of arterial and venous thrombosis.<\/jats:p>","DOI":"10.1007\/s00415-021-10441-9","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:13:40Z","timestamp":1613607220000},"page":"3480-3492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Cerebrovascular manifestations in hematological diseases: an update"],"prefix":"10.1007","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2343-9097","authenticated-orcid":false,"given":"Jos\u00e9 M.","family":"Ferro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4505-2299","authenticated-orcid":false,"given":"Joana","family":"Infante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,13]]},"reference":[{"key":"10441_CR1","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1161\/01.STR.26.8.1463","volume":"26","author":"A Arboix","year":"1995","unstructured":"Arboix A, Besses C, Acin P et al (1995) Ischemic stroke as first manifestation of essential thrombocythemia. Report of six cases. Stroke 26:1463\u20131466","journal-title":"Stroke"},{"issue":"11","key":"10441_CR2","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/s0035-3787(04)71140-6","volume":"160","author":"A Gonthier","year":"2004","unstructured":"Gonthier A, Bogousslavsky J (2004) Cerebral infarction of arterial origin and haematological causation: the Lausanne experience and a review of the literature. Rev Neurol (Paris) 160(11):1029\u20131039. https:\/\/doi.org\/10.1016\/s0035-3787(04)71140-6 (article in French)","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"10441_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1212\/CON.0000000000000858","volume":"26","author":"AE Merkler","year":"2020","unstructured":"Merkler AE (2020) Blood cell disorders and the nervous system. Continuum (Minneap Minn) 26(3):659\u2013674. https:\/\/doi.org\/10.1212\/CON.0000000000000858","journal-title":"Continuum (Minneap Minn)"},{"issue":"22","key":"10441_CR4","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1056\/NEJMra1406186","volume":"376","author":"JL Spivak","year":"2017","unstructured":"Spivak JL (2017) Myeloproliferative neoplasms. N Engl J Med 376(22):2168\u20132181. https:\/\/doi.org\/10.1056\/NEJMra1406186","journal-title":"N Engl J Med"},{"key":"10441_CR5","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/B978-0-7020-4087-0.00072-3","volume":"120","author":"JF de Lacerda","year":"2014","unstructured":"de Lacerda JF, Oliveira SN, Ferro JM (2014) Chronic myeloproliferative diseases. Handb Clin Neurol 120:1073\u20131081","journal-title":"Handb Clin Neurol"},{"key":"10441_CR6","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMcp1816082","volume":"381","author":"A Tefferi","year":"2019","unstructured":"Tefferi A, Pardanani A (2019) Essential thrombocythemia. N Engl J Med 381:2135\u20132144. https:\/\/doi.org\/10.1056\/NEJMcp1816082","journal-title":"N Engl J Med"},{"key":"10441_CR7","doi-asserted-by":"publisher","first-page":"955","DOI":"10.2147\/CLEP.S216787","volume":"11","author":"H Frederiksen","year":"2019","unstructured":"Frederiksen H, Sz\u00e9pligeti S, Bak M, Ghanima W, Hasselbalch HC, Christiansen CF (2019) Vascular diseases in patients with chronic myeloproliferative neoplasms\u2014impact of comorbidity. Clin Epidemiol 11:955\u2013967. https:\/\/doi.org\/10.2147\/CLEP.S216787","journal-title":"Clin Epidemiol"},{"issue":"4","key":"10441_CR8","first-page":"76","volume":"10","author":"G Ajebo","year":"2020","unstructured":"Ajebo G, Patel SJ, Kota V, Guddati AK (2020) A nationwide analysis of outcomes of stroke in hospitalized patients with essential thrombocythemia: 2006 to 2014. Am J Blood Res 10(4):76\u201381","journal-title":"Am J Blood Res"},{"issue":"6","key":"10441_CR9","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/ene.13907","volume":"26","author":"MI Stefanou","year":"2019","unstructured":"Stefanou MI, Richter H, H\u00e4rtig F et al (2019) Recurrent ischaemic cerebrovascular events as presenting manifestations of myeloproliferative neoplasms. Eur J Neurol 26(6):903-e64. https:\/\/doi.org\/10.1111\/ene.13907","journal-title":"Eur J Neurol"},{"key":"10441_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.blre.2016.06.001","volume":"30","author":"T Barbui","year":"2016","unstructured":"Barbui T, Thiele J, Gisslinger H et al (2016) The 2016 revision of WHO classification of myeloproliferative neoplasms: clinical and molecular advances. Blood Rev 30:453\u2013459","journal-title":"Blood Rev"},{"key":"10441_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neurol.2016.09.010","volume":"172","author":"E Ong","year":"2016","unstructured":"Ong E, Barraco F, Nighoghossian N et al (2016) Cerebrovascular events as presenting manifestations of myeloproliferative neoplasm. Rev Neurol (Paris) 172:703\u2013708","journal-title":"Rev Neurol (Paris)"},{"key":"10441_CR12","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1161\/STROKEAHA.110.581223","volume":"41","author":"B Miranda","year":"2010","unstructured":"Miranda B, Ferro JM, Canh\u00e3o P et al (2010) Venous thromboembolic events after cerebral vein thrombosis. Stroke 41:1901\u20131906","journal-title":"Stroke"},{"issue":"10","key":"10441_CR13","doi-asserted-by":"publisher","first-page":"105069","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105069","volume":"29","author":"A Momozaki","year":"2020","unstructured":"Momozaki A, Masuoka J, Furukawa T et al (2020) Hemorrhagic stroke associated with essential thrombocythemia: case report and literature review. J Stroke Cerebrovasc Dis 29(10):105069. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105069","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"8","key":"10441_CR14","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1007\/s00415-019-09347-4","volume":"266","author":"M Sugiyama","year":"2019","unstructured":"Sugiyama M, Ueno Y, Kamo H et al (2019) Specific mechanisms of subarachnoid hemorrhage accompanied by ischemic stroke in essential thrombocythemia: two case reports and a literature review. J Neurol 266(8):1869\u20131878. https:\/\/doi.org\/10.1007\/s00415-019-09347-4","journal-title":"J Neurol"},{"issue":"1","key":"10441_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41408-017-0042-7","volume":"8","author":"A Tefferi","year":"2018","unstructured":"Tefferi A, Vannucchi AM, Barbui T (2018) Polycythemia vera treatment algorithm 2018. Blood Cancer J 8(1):3. https:\/\/doi.org\/10.1038\/s41408-017-0042-7","journal-title":"Blood Cancer J"},{"issue":"1","key":"10441_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41408-017-0041-8","volume":"8","author":"A Tefferi","year":"2018","unstructured":"Tefferi A, Vannucchi AM, Barbui T (2018) Essential thrombocythemia treatment algorithm 2018. Blood Cancer J 8(1):2. https:\/\/doi.org\/10.1038\/s41408-017-0041-8","journal-title":"Blood Cancer J"},{"issue":"10","key":"10441_CR17","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/ene.13381","volume":"24","author":"JM Ferro","year":"2017","unstructured":"Ferro JM, Bousser MG, Canh\u00e3o P et al (2017) European stroke organization guideline for the diagnosis and treatment of cerebral venous thrombosis\u2014endorsed by the European academy of neurology. Eur J Neurol 24(10):1203\u20131213","journal-title":"Eur J Neurol"},{"issue":"1","key":"10441_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.clml.2017.09.008","volume":"18","author":"C Del Prete","year":"2018","unstructured":"Del Prete C, Kim T, Lansigan F, Shatzel J, Friedman H (2018) The epidemiology and clinical associations of stroke in patients with acute myeloid leukemia: a review of 10,972 admissions from the 2012 national inpatient sample. Clin Lymphoma Myeloma Leuk 18(1):74-77.e1. https:\/\/doi.org\/10.1016\/j.clml.2017.09.008","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10441_CR19","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/j.wneu.2020.06.091","volume":"144","author":"A Raghavan","year":"2020","unstructured":"Raghavan A, Wright CH, Wright JM et al (2020) Outcomes and clinical characteristics of intracranial hemorrhage in patients with hematologic malignancies: a systematic literature review. World Neurosurg 144:e15\u2013e24. https:\/\/doi.org\/10.1016\/j.wneu.2020.06.091 (PMID: 32565374)","journal-title":"World Neurosurg"},{"issue":"1","key":"10441_CR20","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/S0049-3848(20)30399-6","volume":"191","author":"MA Sanz","year":"2020","unstructured":"Sanz MA, Montesinos P (2020) Advances in the management of coagulopathy in acute promyelocytic leukemia. Thromb Res 191(1):S63\u2013S67. https:\/\/doi.org\/10.1016\/S0049-3848(20)30399-6","journal-title":"Thromb Res"},{"issue":"4","key":"10441_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/bjh.13162","volume":"168","author":"S Ranta","year":"2015","unstructured":"Ranta S, Tuckuviene R, M\u00e4kipernaa A, Albertsen BK, Frisk T, Tedg\u00e5rd U, J\u00f3nsson \u00d3G, Pruunsild K, Andersson NG, Gunnes MW, Trakymiene SS, Frandsen T, Heyman M, Ruud E, Helgestad J (2015) Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia\u2014a multicentre study from the Nordic society of paediatric haematology and oncology. Br J Haematol 168(4):547\u201352. https:\/\/doi.org\/10.1111\/bjh.13162 (Epub 2014 Oct 7)","journal-title":"Br J Haematol"},{"issue":"2","key":"10441_CR22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/rth2.12182","volume":"3","author":"ILM Klaassen","year":"2019","unstructured":"Klaassen ILM, Lauw MN, Fiocco M, van der Sluis IM, Pieters R, Middeldorp S, van de Wetering MD, de Groot-Kruseman HA, van Ommen CH (2019) Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: risk factors and effect on prognosis. Res Pract Thromb Haemost 3(2):234\u2013241. https:\/\/doi.org\/10.1002\/rth2.12182","journal-title":"Res Pract Thromb Haemost"},{"issue":"7","key":"10441_CR23","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.041","volume":"24","author":"SM Zuurbier","year":"2015","unstructured":"Zuurbier SM, Lauw MN, Coutinho JM, Majoie CB, van der Holt B, Cornelissen JJ, Middeldorp S, Biemond BJ, Stam J (2015) Clinical course of cerebral venous thrombosis in adult acute lymphoblastic leukemia. J Stroke Cerebrovasc Dis 24(7):1679\u201384. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2015.03.041","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10441_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26694","author":"KM Ghanem","year":"2017","unstructured":"Ghanem KM, Dhayni RM, Al-Aridi C, Tarek N, Tamim H, Chan AKC, Saab R, Abboud MR, El-Solh H, Muwakkit SA (2017) Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: risk factors and management. Pediatr Blood Cancer. https:\/\/doi.org\/10.1002\/pbc.26694","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10441_CR25","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/bjh.14231","volume":"179","author":"KM Musgrave","year":"2017","unstructured":"Musgrave KM, van Delft FW, Avery PJ, Clack RM, Chalmers EA, Qureshi A, Vora AJ, Biss TT (2017) Cerebral sinovenous thrombosis in children and young adults with acute lymphoblastic leukaemia\u2014a cohort study from the United Kingdom. Br J Haematol 179(4):667\u2013669. https:\/\/doi.org\/10.1111\/bjh.14231","journal-title":"Br J Haematol"},{"issue":"6","key":"10441_CR26","doi-asserted-by":"publisher","first-page":"e407","DOI":"10.1097\/MPH.0000000000001832","volume":"42","author":"Y Ren","year":"2020","unstructured":"Ren Y, Chang L, Zhao B et al (2020) Venous thromboembolism after peripherally inserted central catheters placement in children with acute leukemia: a single-center retrospective cohort study. J Pediatr Hematol Oncol 42(6):e407\u2013e409. https:\/\/doi.org\/10.1097\/MPH.0000000000001832","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10441_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11239-013-0988-7","volume":"38","author":"KR Lee","year":"2014","unstructured":"Lee KR, Subrayan V, Win MM, Mohamad NF, Patel D (2014) ATRA-induced cerebral sinus thrombosis. J Thromb Thrombolysis 38(1):87\u20139. https:\/\/doi.org\/10.1007\/s11239-013-0988-7","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"10441_CR28","doi-asserted-by":"publisher","first-page":"104683","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104683","volume":"29","author":"MJ Pinto","year":"2020","unstructured":"Pinto MJ, Medeiros PB, Pr\u00edncipe F, Carvalho M (2020) Cerebral venous thrombosis in hematological malignancy: balancing the risks. J Stroke Cerebrovasc Dis 29(4):104683. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.104683","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"10441_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/1941874419852196","volume":"10","author":"KA Kasischke","year":"2020","unstructured":"Kasischke KA, Peguero EN, Sriaroon C et al (2020) Immediate transfer for clot extraction in a young woman with leukemia and asparaginase-associated acute cerebral vein thrombosis. Neurohospitalist 10(1):58\u201363. https:\/\/doi.org\/10.1177\/1941874419852196","journal-title":"Neurohospitalist"},{"issue":"6","key":"10441_CR30","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/jth.14015","volume":"16","author":"BTS Bannow","year":"2018","unstructured":"Bannow BTS, Lee A, Khorana AA et al (2018) Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH. J Thromb Haemost 16(6):1246\u20131249. https:\/\/doi.org\/10.1111\/jth.14015","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10441_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/jth.14671","volume":"18","author":"JI Zwicker","year":"2020","unstructured":"Zwicker JI, Wang TF, DeAngelo DJ, Lauw MN, Connors JM, Falanga A, McMasters M, Carrier M (2020) The prevention and management of asparaginase-related venous thromboembolism in adults: guidance from the SSC on hemostasis and malignancy of the ISTH. J Thromb Haemost 18(2):278\u2013284. https:\/\/doi.org\/10.1111\/jth.14671","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10441_CR32","doi-asserted-by":"publisher","first-page":"5172","DOI":"10.1038\/s41467-019-13120-6","volume":"10","author":"NG Zaorsky","year":"2019","unstructured":"Zaorsky NG, Zhang Y, Tchelebi LT, Mackley HB, Chinchilli VM, Zacharia BE (2019) Stroke among cancer patients. Nat Commun 10(1):5172. https:\/\/doi.org\/10.1038\/s41467-019-13120-6","journal-title":"Nat Commun"},{"issue":"6","key":"10441_CR33","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/practneurol-2019-002205","volume":"19","author":"N Smith","year":"2019","unstructured":"Smith N, Kimberger K, Parrish C, Currie S, Butterworth S, Alty J (2019) Multiple myeloma with multiple neurological presentations. Pract Neurol 19(6):511\u2013517. https:\/\/doi.org\/10.1136\/practneurol-2019-002205","journal-title":"Pract Neurol"},{"issue":"6","key":"10441_CR34","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/1076029615625825","volume":"22","author":"MP Crowley","year":"2016","unstructured":"Crowley MP, Kevane B, O\u2019Shea SI et al (2016) Plasma thrombin generation and sensitivity to activated protein C among patients with myeloma and monoclonal gammopathy of undetermined significance. Clin Appl Thromb Hemost 22(6):554\u201362","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"10441_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/cancers12010191","volume":"12","author":"D Fotiou","year":"2020","unstructured":"Fotiou D, Gavriatopoulou M, Terpos E (2020) Multiple myeloma and thrombosis: prophylaxis and risk prediction tools. Cancers (Basel) 12(1):191. https:\/\/doi.org\/10.3390\/cancers12010191","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10441_CR36","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/WNF.0000000000000310","volume":"41","author":"E Celis","year":"2018","unstructured":"Celis E, Leci\u00f1ana MA, Rodr\u00edguez-Pardo J, Fuentes D, D\u00edez-Tejedor E (2018) Increased risk of ischemic stroke in multiple myeloma associated with lenalidomide treatment: a case report and review of the literature. Clin Neuropharmacol 41(6):232\u2013235. https:\/\/doi.org\/10.1097\/WNF.0000000000000310","journal-title":"Clin Neuropharmacol"},{"key":"10441_CR37","doi-asserted-by":"publisher","first-page":"5180424","DOI":"10.1155\/2019\/5180424.eCollection2019","volume":"2019","author":"D Osafehinti","year":"2019","unstructured":"Osafehinti D, Zivari K (2019) Case of stroke from cerebral vasculitis following carfilzomib, lenalidomide, and dexamethasone therapy in a patient with relapsing multiple myeloma. Case Rep Hematol 2019:5180424. https:\/\/doi.org\/10.1155\/2019\/5180424.eCollection2019","journal-title":"Case Rep Hematol"},{"key":"10441_CR38","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.2147\/CLEP.S172306.eCollection","volume":"10","author":"E Horv\u00e1th-Puh\u00f3","year":"2018","unstructured":"Horv\u00e1th-Puh\u00f3 E, Suttorp MM, Frederiksen H et al (2018) (2018) Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma. Clin Epidemiol 10:1371\u20131380. https:\/\/doi.org\/10.2147\/CLEP.S172306.eCollection","journal-title":"Clin Epidemiol"},{"issue":"11","key":"10441_CR39","doi-asserted-by":"publisher","first-page":"e0166627","DOI":"10.1371\/journal.pone.0166627","volume":"11","author":"A Hinduja","year":"2016","unstructured":"Hinduja A, Limaye K, Ravilla R, Sasapu A, Papanikolaou X, Wei L, Torbey M, Waheed S (2016) Spectrum of cerebrovascular disease in patients with multiple myeloma undergoing chemotherapy-results of a case control study. PLoS ONE 11(11):e0166627. https:\/\/doi.org\/10.1371\/journal.pone.0166627 (eCollection 2016. Erratum in Hinduja A, Limaye K, Ravilla R, Sasapu A, Papanikolaou X, Wei L, Torbey M, Waheed S (2017) Correction: spectrum of cerebrovascular disease in patients with multiple myeloma undergoing chemotherapy-results of a case control study. PLoS One 12(3):e0175218. doi: 0.1371\/journal.pone.0175218 eCollection 2017)","journal-title":"PLoS ONE"},{"issue":"4","key":"10441_CR40","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/hon.2340","volume":"35","author":"G-Y Lee","year":"2017","unstructured":"Lee G-Y, Lee Y-T, Yeh C-M et al (2017) Risk of stroke in patients with newly diagnosed multiple myeloma: a retrospective cohort study. Hematol Oncol 35(4):726\u2013733. https:\/\/doi.org\/10.1002\/hon.2340","journal-title":"Hematol Oncol"},{"issue":"2","key":"10441_CR41","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/sj.leu.2405062","volume":"22","author":"A Palumbo","year":"2008","unstructured":"Palumbo A, Rajkumar SV, Dimopoulos MA et al (2008) Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia 22(2):414\u201323. https:\/\/doi.org\/10.1038\/sj.leu.2405062","journal-title":"Leukemia"},{"issue":"7","key":"10441_CR42","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/ajh.25495","volume":"94","author":"A Dispenzieri","year":"2019","unstructured":"Dispenzieri A (2019) POEMS syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol 94(7):812\u2013827. https:\/\/doi.org\/10.1002\/ajh.25495","journal-title":"Am J Hematol"},{"issue":"14","key":"10441_CR43","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1182\/bloodadvances.2020001865","volume":"4","author":"J Feng","year":"2020","unstructured":"Feng J, Gao XM, Zhao H et al (2020) Ischemic stroke in patients with POEMS syndrome. Blood Adv 4(14):3427\u20133434. https:\/\/doi.org\/10.1182\/bloodadvances.2020001865","journal-title":"Blood Adv"},{"issue":"51","key":"10441_CR44","doi-asserted-by":"publisher","first-page":"89406","DOI":"10.18632\/oncotarget.20131","volume":"8","author":"FW Fu","year":"2017","unstructured":"Fu FW, Rao J, Zheng YY, Wang HL, Yang JG, Zheng GQ (2017) Ischemic stroke in patients with POEMS syndrome: a case report and comprehensive analysis of literature. Oncotarget. 8(51):89406\u201389424. https:\/\/doi.org\/10.18632\/oncotarget.20131","journal-title":"Oncotarget."},{"issue":"10","key":"10441_CR45","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1182\/bloodadvances.2020001492","volume":"4","author":"Z Sayar","year":"2020","unstructured":"Sayar Z, Weatherill A, Keddie S, Sive J, Lunn MP, Thomas M, D\u2019Sa S (2020) High rates of venous and arterial thrombotic events in patients with POEMS syndrome: results from the UCLH (UK) POEMS registry. Blood Adv 4(10):2139\u20132142. https:\/\/doi.org\/10.1182\/bloodadvances.2020001492","journal-title":"Blood Adv"},{"issue":"6","key":"10441_CR46","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.12.039","volume":"27","author":"A Mitsutake","year":"2018","unstructured":"Mitsutake A, Matsumoto H, Hatano K, Irie K, Tsukada N, Hashida H (2018) Lenalidomide-induced ischemic cerebrovascular disease in polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome. J Stroke Cerebrovasc Dis 27(6):e102\u2013e103. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.12.039","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"7","key":"10441_CR47","doi-asserted-by":"publisher","first-page":"e229428","DOI":"10.1136\/bcr-2019-229428","volume":"12","author":"L Vasilevskiy","year":"2019","unstructured":"Vasilevskiy L, Akhondi H, Wierman A (2019) POEMS syndrome complicated by ischaemic stroke and cerebral vasculitis. BMJ Case Rep 12(7):e229428. https:\/\/doi.org\/10.1136\/bcr-2019-229428","journal-title":"BMJ Case Rep"},{"issue":"8","key":"10441_CR48","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s10072-017-2965-y","volume":"38","author":"S Forlivesi","year":"2017","unstructured":"Forlivesi S, Bacchin R, Cappellari M, Dall\u2019Ora E, Dossi RC, Bonetti B (2017) Cerebral large-vessel vasculitis as an unusual manifestation of POEMS syndrome. Neurol Sci 38(8):1529\u20131531. https:\/\/doi.org\/10.1007\/s10072-017-2965-y","journal-title":"Neurol Sci"},{"issue":"1","key":"10441_CR49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2176\/nmccrj.cr.2016-0106","volume":"4","author":"I Yamaguchi","year":"2016","unstructured":"Yamaguchi I, Satomi J, Yamamoto N et al (2016) Coexistence of quasi-moyamoya disease and poems syndrome in a patient with intracranial hemorrhage: a case report and literature review. NMC Case Rep J 4(1):5\u20139. https:\/\/doi.org\/10.2176\/nmccrj.cr.2016-0106 (eCollection 2017 Jan)","journal-title":"NMC Case Rep J"},{"key":"10441_CR50","doi-asserted-by":"publisher","first-page":"116738","DOI":"10.1016\/j.jns.2020.116738","volume":"412","author":"T Sekiguchi","year":"2020","unstructured":"Sekiguchi T, Ishibashi S, Sasame J et al (2020) Recurrent stroke due to quasi-moyamoya disease associated with POEMS syndrome: an autopsy case. J Neurol Sci 412:116738. https:\/\/doi.org\/10.1016\/j.jns.2020.116738","journal-title":"J Neurol Sci"},{"key":"10441_CR51","doi-asserted-by":"publisher","first-page":"17028","DOI":"10.1038\/nrdp.2017.28","volume":"3","author":"A Hill","year":"2017","unstructured":"Hill A, DeZern AE, Kinoshita T, Brodsky RA (2017) Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Primers 3:17028. https:\/\/doi.org\/10.1038\/nrdp.2017.28","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10441_CR52","doi-asserted-by":"publisher","first-page":"13458","DOI":"10.1038\/s41598-018-31547-7","volume":"8","author":"F Alashkar","year":"2018","unstructured":"Alashkar F, Schemuth HP, Nensa F et al (2018) The role of whole-body magnetic resonance imaging (WB-MRI) in patients with paroxysmal nocturnal hemoglobinuria (PNH). Sci Rep 8(1):13458. https:\/\/doi.org\/10.1038\/s41598-018-31547-7","journal-title":"Sci Rep"},{"key":"10441_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-213603","author":"L Azevedo","year":"2016","unstructured":"Azevedo L, Costa MR, Fonseca AC, Melo TP (2016) Recurrent cerebral ischaemic events in the setting of paroxysmal nocturnal haemoglobinuria. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2015-213603","journal-title":"BMJ Case Rep"},{"issue":"10","key":"10441_CR54","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.07.001","volume":"26","author":"AT Meira","year":"2017","unstructured":"Meira AT, Froehner GS, Trindade AP, Bazan SGZ, Braga GP, Bazan R (2017) Multiple lacunar infarcts in paroxysmal nocturnal hemoglobinuria. J Stroke Cerebrovasc Dis 26(10):e199\u2013e202. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.07.001","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"23","key":"10441_CR55","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.4103\/0366-6999.246065","volume":"131","author":"Z-J Cheng","year":"2018","unstructured":"Cheng Z-J, Shen Y-Y, Warsame IM et al (2018) Moyamoya syndrome caused by paroxysmal nocturnal hemoglobinuria. Chin Med J (Engl) 131(23):2874\u20132876. https:\/\/doi.org\/10.4103\/0366-6999.246065","journal-title":"Chin Med J (Engl)"},{"issue":"7","key":"10441_CR56","first-page":"11617","volume":"8","author":"D Ding","year":"2015","unstructured":"Ding D, Li K, Li G, Long X (2015) Posterior reversible encephalopathy syndrome following paroxysmal nocturnal hemoglobinuria: a case report and literature review. Int J Clin Exp Med 8(7):11617\u201320 (eCollection 2015)","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"10441_CR57","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41598-017-18936-0","volume":"8","author":"W Barcellini","year":"2018","unstructured":"Barcellini W, Scola E, Lanfranconi S et al (2018) Paroxysmal nocturnal hemoglobinuria (Pnh): brain MRI ischemic lesions in neurologically asymtomatic patients. Sci Rep 8(1):476. https:\/\/doi.org\/10.1038\/s41598-017-18936-0","journal-title":"Sci Rep"},{"issue":"1","key":"10441_CR58","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1097\/MD.0000000000000362","volume":"94","author":"E Meppiel","year":"2015","unstructured":"Meppiel E, Crassard I, de Latour RP et al (2015) Cerebral venous thrombosis in paroxysmal nocturnal hemoglobinuria: a series of 15 cases and review of the literature. Medicine (Baltimore) 94(1):e362. https:\/\/doi.org\/10.1097\/MD.0000000000000362","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10441_CR59","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1055\/s-0040-1708541","volume":"46","author":"R Blennerhassett","year":"2020","unstructured":"Blennerhassett R, Curnow J, Pasalic L (2020) Immune-mediated thrombotic thrombocytopenic purpura: a narrative review of diagnosis and treatment in adults. Semin Thromb Hemost. 46(3):289\u2013301. https:\/\/doi.org\/10.1055\/s-0040-1708541","journal-title":"Semin Thromb Hemost."},{"issue":"4","key":"10441_CR60","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa1806311","volume":"380","author":"M Scully","year":"2019","unstructured":"Scully M, Cataland SR, Peyvandi F et al (2019) Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura. N Engl J Med 380(4):335\u2013346. https:\/\/doi.org\/10.1056\/NEJMoa1806311","journal-title":"N Engl J Med"},{"issue":"11","key":"10441_CR61","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1007\/s00134-019-05736-5","volume":"45","author":"E Azoulay","year":"2019","unstructured":"Azoulay E, Bauer PR, Mariotte E et al (2019) Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura. Intensive Care Med 45(11):1518\u20131539. https:\/\/doi.org\/10.1007\/s00134-019-05736-5","journal-title":"Intensive Care Med"},{"issue":"11","key":"10441_CR62","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.07.017","volume":"27","author":"C Tomich","year":"2018","unstructured":"Tomich C, Debruxelles S, Delmas Y et al (2018) Immune-thrombotic thrombocytopenic purpura is a rare cause of ischemic stroke in young adults: case reports and literature review. J Stroke Cerebrovasc Dis 27(11):3163\u20133171. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.07.017","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"13","key":"10441_CR63","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1182\/blood.2019001056","volume":"134","author":"H Upreti","year":"2019","unstructured":"Upreti H, Kasmani J, Dane K et al (2019) Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors. Blood 134(13):1037\u20131045. https:\/\/doi.org\/10.1182\/blood.2019001056","journal-title":"Blood"},{"issue":"6","key":"10441_CR64","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.03.011","volume":"28","author":"D Beauvais","year":"2019","unstructured":"Beauvais D, Venditti L, Chassin O et al (2019) Inherited thrombotic thrombocytopenic purpura revealed by recurrent strokes in a male adult: case report and literature review. J Stroke Cerebrovasc Dis 28(6):1537\u20131539. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2019.03.011","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"10","key":"10441_CR65","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.3324\/haematol.2019.216796","volume":"104","author":"HA van Dorland","year":"2019","unstructured":"van Dorland HA, Taleghani MM, Sakai K et al (2019) The international hereditary thrombotic thrombocytopenic purpura registry: key findings at enrolment until 2017. Haematologica 104(10):2107\u20132115. https:\/\/doi.org\/10.3324\/haematol.2019.216796","journal-title":"Haematologica"},{"issue":"15","key":"10441_CR66","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1182\/blood-2018-11-884700","volume":"133","author":"F Alwan","year":"2019","unstructured":"Alwan F, Vendramin C, Liesner R et al (2019) Characterization and treatment of congenital thrombotic thrombocytopenic purpura. Blood 133(15):1644\u20131651. https:\/\/doi.org\/10.1182\/blood-2018-11-884700","journal-title":"Blood"},{"issue":"4","key":"10441_CR67","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4103\/aian.AIAN_59_19","volume":"23","author":"V Bhat","year":"2020","unstructured":"Bhat V, Rao SS, Balakrishnan C (2020) Posterior reversible encephalopathy syndrome in thrombotic thrombocytopenic purpura. Ann Indian Acad Neurol 23(4):555\u2013557","journal-title":"Ann Indian Acad Neurol"},{"issue":"10","key":"10441_CR68","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.07.012","volume":"26","author":"N Noorbakhsh-Sabet","year":"2017","unstructured":"Noorbakhsh-Sabet N, Pulakanti VC, Zand R (2017) Uncommon causes of cerebral microbleeds. J Stroke Cerebrovasc Dis 26(10):2043\u20132049. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.07.012","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"11","key":"10441_CR69","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.08.037","volume":"25","author":"N Noorbakhsh-Sabet","year":"2016","unstructured":"Noorbakhsh-Sabet N, Zand R (2016) Thrombotic thrombocytopenic purpura with concomitant progressive cerebral microbleeds. J Stroke Cerebrovasc Dis 25(11):e214\u2013e215. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2016.08.037","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"16","key":"10441_CR70","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMra1510865","volume":"376","author":"FB Piel","year":"2017","unstructured":"Piel FB, Steinberg MH, Rees DC (2017) Sickle cell disease. N Engl J Med 376(16):1561\u20131573. https:\/\/doi.org\/10.1056\/NEJMra1510865","journal-title":"N Engl J Med"},{"issue":"10091","key":"10441_CR71","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","volume":"390","author":"RE Ware","year":"2017","unstructured":"Ware RE, de Montalembert M, Tshilolo L, Abboud MR (2017) Sickle cell disease. Lancet 390(10091):311\u2013323. https:\/\/doi.org\/10.1016\/S0140-6736(17)30193-9","journal-title":"Lancet"},{"issue":"8","key":"10441_CR72","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/jpepsy\/jsz031","volume":"44","author":"KV Prussien","year":"2019","unstructured":"Prussien KV, Jordan LC, DeBaun MR, Compas BE (2019) Cognitive function in sickle cell disease across domains, cerebral infarct status, and the lifespan: a meta-analysis. J Pediatr Psychol 44(8):948\u2013958. https:\/\/doi.org\/10.1093\/jpepsy\/jsz031","journal-title":"J Pediatr Psychol"},{"issue":"2","key":"10441_CR73","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/STROKEAHA.118.020482","volume":"50","author":"KP Guilliams","year":"2019","unstructured":"Guilliams KP, Fields ME, Dowling MM (2019) Advances in understanding ischemic stroke physiology and the impact of vasculopathy in children with sickle cell disease. Stroke 50(2):266\u2013273. https:\/\/doi.org\/10.1161\/STROKEAHA.118.020482","journal-title":"Stroke"},{"issue":"3","key":"10441_CR74","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/03630269.2019.1651734","volume":"43","author":"MK Wang","year":"2019","unstructured":"Wang MK, Shergill R, Jefkins M, Cheung J (2019) A sickle cell disease patient with dural venous sinus thrombosis: a case report and literature review. Hemoglobin 43(3):193\u2013197. https:\/\/doi.org\/10.1080\/03630269.2019.1651734","journal-title":"Hemoglobin"},{"issue":"16","key":"10441_CR75","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1182\/blood-2018-04-841247","volume":"132","author":"AL Ford","year":"2018","unstructured":"Ford AL, Ragan DK, Fellah S et al (2018) Silent infarcts in sickle cell disease occur in the border zone region and are associated with low cerebral blood flow. Blood 132(16):1714\u20131723. https:\/\/doi.org\/10.1182\/blood-2018-04-841247","journal-title":"Blood"},{"issue":"8","key":"10441_CR76","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1182\/bloodadvances.2019001142","volume":"4","author":"MR DeBaun","year":"2020","unstructured":"DeBaun MR, Jordan LC, King AA, Schatz J, Vichinsky E, Fox CK, McKinstry RC, Telfer P, Kraut MA, Daraz L, Kirkham FJ, Murad MH (2020) American society of hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv 4(8):1554\u20131588. https:\/\/doi.org\/10.1182\/bloodadvances.2019001142","journal-title":"Blood Adv"},{"issue":"2","key":"10441_CR77","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1056\/NEJMoa1813598","volume":"380","author":"L Tshilolo","year":"2019","unstructured":"Tshilolo L, Tomlinson G, Williams TN et al (2019) Hydroxyurea for children with sickle cell anemia in Sub-Saharan Africa. N Engl J Med 380(2):121\u2013131. https:\/\/doi.org\/10.1056\/NEJMoa1813598","journal-title":"N Engl J Med"},{"issue":"3","key":"10441_CR78","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1161\/STROKEAHA.116.01541","volume":"48","author":"RJ Adams","year":"2017","unstructured":"Adams RJ, Cox M, Ozark SD et al (2017) Coexistent sickle cell disease has no impact on the safety or outcome of lytic therapy in acute ischemic stroke: findings from get with the guidelines-stroke. Stroke 48(3):686\u2013691. https:\/\/doi.org\/10.1161\/STROKEAHA.116.01541","journal-title":"Stroke"},{"issue":"17","key":"10441_CR79","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1182\/blood-2011-11-392340","volume":"119","author":"RE Ware","year":"2012","unstructured":"Ware RE, Helms RW, SWiTCH Investigators (2012) Stroke with transfusions changing to hydroxyurea (SWiTCH). Blood 119(17):3925\u201332. https:\/\/doi.org\/10.1182\/blood-2011-11-392340","journal-title":"Blood"},{"key":"10441_CR80","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.wneu.2018.11.157","volume":"123","author":"P Aguilar-Salinas","year":"2019","unstructured":"Aguilar-Salinas P, Hayward K, Santos R et al (2019) Surgical revascularization for pediatric patients with sickle cell disease and moyamoya disease in the prevention of ischemic strokes: a single-center case series and a systematic review. World Neurosurg 123:435-442.e8. https:\/\/doi.org\/10.1016\/j.wneu.2018.11.157","journal-title":"World Neurosurg"},{"key":"10441_CR81","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1007\/s00415-016-8377-8","volume":"264","author":"M Fischer","year":"2017","unstructured":"Fischer M, Schmutzhard E (2017) Posterior reversible encephalopathy syndrome. J Neurol 264:1608\u20131616. https:\/\/doi.org\/10.1007\/s00415-016-8377-8","journal-title":"J Neurol"},{"issue":"4","key":"10441_CR82","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jemermed.2016.11.016","volume":"52","author":"P Rogers","year":"2017","unstructured":"Rogers P, Pan WJ, Drachtman RA, Haines C (2017) A stroke mimic: methotrexate-induced neurotoxicity in the emergency department. J Emerg Med 52(4):559\u2013561. https:\/\/doi.org\/10.1016\/j.jemermed.2016.11.016","journal-title":"J Emerg Med"},{"issue":"6","key":"10441_CR83","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s12185-018-2525-0","volume":"108","author":"K Watanabe","year":"2018","unstructured":"Watanabe K, Arakawa Y, Oguma E, Uehara T, Yanagi M, Oyama C, Ikeda Y, Sasaki K, Isobe K, Mori M, Hanada R, Koh K (2018) Characteristics of methotrexate-induced stroke-like neurotoxicity. Int J Hematol 108(6):630\u2013636. https:\/\/doi.org\/10.1007\/s12185-018-2525-0","journal-title":"Int J Hematol"},{"issue":"1","key":"10441_CR84","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/1941874417698324","volume":"8","author":"JD Avila","year":"2018","unstructured":"Avila JD (2018) Methotrexate-induced neurotoxicity: an uncommon stroke mimic. Neurohospitalist 8(1):46\u201347. https:\/\/doi.org\/10.1177\/1941874417698324","journal-title":"Neurohospitalist"},{"issue":"16","key":"10441_CR85","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1182\/bloodadvances.2020002228","volume":"4","author":"P Strati","year":"2020","unstructured":"Strati P, Nastoupil LJ, Westin J et al (2020) Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv 4(16):3943\u20133951. https:\/\/doi.org\/10.1182\/bloodadvances.2020002228","journal-title":"Blood Adv"},{"issue":"11","key":"10441_CR86","doi-asserted-by":"publisher","first-page":"e229946","DOI":"10.1136\/bcr-2019-229946","volume":"12","author":"MJ Kersten","year":"2021","unstructured":"Kersten MJ, van Ettekoven CN, Heijink DM (2021) Unexpected neurologic complications following a novel lymphoma treatment \u2018expected\u2019 to give rise to neurologic toxicity. BMJ Case Rep 12(11):e229946. https:\/\/doi.org\/10.1136\/bcr-2019-229946 (PMID: 31722870 PMCID: PMC6855863 available on 2021-11-12)","journal-title":"BMJ Case Rep"},{"key":"10441_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2020.05.006","author":"MA Sheikh","year":"2020","unstructured":"Sheikh MA, Toledano M, Ahmed S, Gul Z, Hashmi SK (2020) Noninfectious neurologic complications of hematopoietic cell transplantation: a systematic review. Hematol Oncol Stem Cell Ther. https:\/\/doi.org\/10.1016\/j.hemonc.2020.05.006 (in press)","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"2","key":"10441_CR88","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/bmt.2017.239","volume":"53","author":"MR Dowling","year":"2018","unstructured":"Dowling MR, Li S, Dey BR, McAfee SL et al (2018) Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact. Bone Marrow Transplant 53(2):199\u2013206. https:\/\/doi.org\/10.1038\/bmt.2017.239","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10441_CR89","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.bbmt.2019.05.024","volume":"25","author":"A Balaguer-Rosello","year":"2019","unstructured":"Balaguer-Rosello A, Bataller L, Pi\u00f1ana JL et al (2019) Noninfectious neurologic complications after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 25(9):1818\u20131824. https:\/\/doi.org\/10.1016\/j.bbmt.2019.05.024","journal-title":"Biol Blood Marrow Transplant"},{"key":"10441_CR90","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13482","author":"R Alblooshi","year":"2020","unstructured":"Alblooshi R, Kanfar S, Lord B et al (2020) Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant. Eur J Haematol. https:\/\/doi.org\/10.1111\/ejh.13482 (Online ahead of print)","journal-title":"Eur J Haematol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10441-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10441-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10441-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T10:50:57Z","timestamp":1697885457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10441-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,13]]},"references-count":90,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10441"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10441-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,13]]},"assertion":[{"value":"12 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}